Bavarian Nordic signs APAC order for smallpox/monkeypox vaccine doses.

NORDIC BUSINESS REPORT-August 3, 2022-Bavarian Nordic signs APAC order for smallpox/monkeypox vaccine doses

(C)2022 M2 COMMUNICATIONS http://www.m2.com

Denmark-based vaccines company Bavarian Nordic A/S (CPH:BAVA) said on Wednesday that it has entered into a new contract with an undisclosed APAC country for the supply of 350,000 doses of its non-replicating JYNNEOS smallpox/monkeypox vaccine.

Deliveries and all revenues under this contract will occur in 2023.

This latest order follows an initial order with the same country for supply in 2022.

Paul Chaplin, president and CEO of Bavarian Nordic, said in a statement: "While governments and health authorities around the world are busy fighting the current monkeypox outbreak...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT